List of insiders holdings for ANI PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
MERIDIAN VENTURE PARTNERS II LP
Meridian Venture Partners II GP L.P.
Meridian Venture Partners II Co.
Brown Robert E. JR
10% Owner		2022-12-12 16:00:422,068,280
0		2,068,280Form 13D
Shanmugam Muthusamy
HEAD OF R & D COO-NOVITIUM OPS		2022-03-21 21:58:1218,460
1,337,620		1,356,080Form 4
SIMES STEPHEN M
Vice Chairman President & CEO		2012-01-27 16:29:26800,000
202,267		1,002,267Form 4
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
Cho Michael
10% Owner		2004-12-13 16:48:36709,819
0		709,819Form 13G
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
10% Owner		2004-12-13 16:48:36709,819
0		709,819Form 13G
Gassert Chad
SVP - CORP. DEV. & STRATEGY		2022-03-22 17:37:550
393,226		393,226Form 4
MARSHBANKS TRACY
Director		2018-05-16 16:22:180
349,934		349,934Form 4
DONENBERG PHILIP B
Sr VP of Finance CFO Secy		2012-01-27 16:33:48329,322
0		329,322Form 4
RAYNOR DANIEL
Director		2018-03-19 16:54:290
289,003		289,003Form 4
Lalwani Nikhil
PRESIDENT & CEO		2022-09-12 20:15:40281,957
0		281,957Form 4
PRZYBYL ARTHUR
President and CEO		2020-04-08 17:54:20190,309
0		190,309Form 4
Snabes Michael C
Sr. VP of Medical Affairs		2012-01-27 16:37:45165,000
0		165,000Form 4
LEHMAN LEAH M
VP Product Development		2005-08-25 15:16:38150,000
0		150,000Form 4/A
CAREY STEPHEN P.
SENIOR VICE PRESIDENT AND CFO		2022-04-29 18:34:09146,633
0		146,633Form 4
Marken James G.
SVP OPS & PROD DEV		2022-08-16 21:01:19117,642
0		117,642Form 4
SHERWIN STEPHEN A
Director		2012-03-30 17:27:49111,760
0		111,760Form 4
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES		2021-03-29 20:11:2387,477
0		87,477Form 4
SULLIVAN LOUIS W
Director		2012-03-30 17:38:2282,898
0		82,898Form 4
Jamnick Robert J.
VP Quality & Product Develop.		2014-05-27 16:38:1177,701
0		77,701Form 4
HO ANGELA
Director		2004-03-22 15:48:2972,137
0		72,137Form 4
Walsh Patrick D
Director		2022-04-29 18:24:2263,437
0		63,437Form 4
Arnold Charlotte C.
Vice President and CFO		2016-04-11 19:10:1662,298
0		62,298Form 4
ROSENOW EDWARD C III
Director		2012-03-30 17:31:0145,540
0		45,540Form 4
KJAER PETER
Director		2010-04-02 16:26:5144,425
0		44,425Form 4
Mutz Christopher
HEAD OF RARE DISEASE		2022-04-29 18:37:1540,854
0		40,854Form 4
HAUGHEY THOMAS
Director		2022-04-29 18:31:5040,251
0		40,251Form 4
Gutwerg Ori
SVP GENERICS		2022-04-29 18:38:0437,644
0		37,644Form 4
NASH DAVID
Director		2022-04-29 18:28:3731,696
0		31,696Form 4
POTTS JOHN T JR
Director		2012-03-30 17:34:4127,657
2924		30,581Form 4
Pera Antonio R
Director		2022-04-29 18:27:2729,762
0		29,762Form 4
Thoma Jeanne
Director		2022-04-29 18:26:0329,334
0		29,334Form 4
MANGANO ROSS J
Director		2014-09-16 16:40:5726,914
0		26,914Form 4
BELL STEVEN J
VP Research & Pre-Clinical Dev		2005-08-25 15:32:2725,000
0		25,000Form 4/A
Cook Meredith
SR. VP GENERAL COUNSEL & SEC.		2022-07-20 16:48:1619,280
0		19,280Form 4
Penn Thomas A.
Director		2019-04-01 16:00:2116,710
0		16,710Form 4
Davis Krista
SVP CHIEF HR OFFICER		2022-09-14 19:06:0116,433
0		16,433Form 4
HOLUBOW FRED
Director		2018-03-22 17:00:3516,144
0		16,144Form 4
TANNENBAUM RENEE P
Director		2022-03-22 17:36:2513,346
0		13,346Form 4
LANKAU PETER A
Director		2016-04-11 18:58:164500
0		4500Form 4
MORGENSTERN VICTOR A
Director		2007-06-14 16:53:130
0		0Form 4